Editas Medicine (EDIT) Prepaid Assets (2015 - 2025)
Editas Medicine (EDIT) reported Prepaid Assets of $2.1 million for Q4 2025, down 33.86% year-over-year from $3.1 million in Q4 2024, and down 33.38% quarter-over-quarter from $3.1 million in Q3 2025.
Editas Medicine (EDIT) Prepaid Assets (2015 - 2025) Analysis & Trends
Editas Medicine (EDIT) has 11 years of Prepaid Assets data on file, last reported at $2.1 million in Q4 2025.
- Prepaid Assets for Q4 2025 came in at $2.1 million, down 33.86% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.1 million (down 33.86% YoY), and the FY2025 annual result was $2.1 million, down 33.86% from the prior year.
- Prepaid Assets declined to $2.1 million in Q4 2025 per EDIT's latest filing, from $3.1 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $9.5 million in Q3 2021 and troughed at $2.1 million in Q4 2025.
- A 5-year average of $6.1 million and a median of $6.6 million in 2023 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2024 and 2025: Prepaid Assets soared 58.2% in 2024, then tumbled 63.14% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $7.2 million in 2021, then increased by 1.9% to $7.3 million in 2022, then increased by 2.67% to $7.5 million in 2023, then slumped by 58.36% to $3.1 million in 2024, then tumbled by 33.86% to $2.1 million in 2025.
- Business Quant data shows EDIT's Prepaid Assets at $2.1 million in Q4 2025, $3.1 million in Q3 2025, and $3.7 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Editas Medicine | 262.77 Mn | 262.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.07 Mn |
| Sep 30, 2025 | 3.11 Mn |
| Jun 30, 2025 | 3.71 Mn |
| Mar 31, 2025 | 3.37 Mn |
| Dec 31, 2024 | 3.14 Mn |
| Sep 30, 2024 | 5.93 Mn |
| Jun 30, 2024 | 7.00 Mn |
| Mar 31, 2024 | 9.14 Mn |
| Dec 31, 2023 | 7.53 Mn |
| Sep 30, 2023 | 6.56 Mn |
| Jun 30, 2023 | 6.72 Mn |
| Mar 31, 2023 | 5.78 Mn |
| Dec 31, 2022 | 7.34 Mn |
| Sep 30, 2022 | 6.89 Mn |
| Jun 30, 2022 | 8.11 Mn |
| Mar 31, 2022 | 7.30 Mn |
| Dec 31, 2021 | 7.20 Mn |
| Sep 30, 2021 | 9.52 Mn |
| Jun 30, 2021 | 5.41 Mn |
| Mar 31, 2021 | 6.31 Mn |